Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine

The FDA announced that they will allow Emergent Biosolutions to resume production of the Johnson and Johnson covid-19 vaccine on Thursday.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting